Patient-control association study of the Leucine-Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patients

Mov Disord. 2013 Dec;28(14):2039-40. doi: 10.1002/mds.25637. Epub 2013 Sep 6.

Authors

Soraya Bardien¹, Janine Blanckenberg, Lize van der Merwe, Matthew J Farrer, Owen A Ross

Affiliation

¹ Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, University of Stellenbosch, Cape Town, South Africa.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Black People
Case-Control Studies
Female
Humans
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
Male
Parkinson Disease / ethnology*
Parkinson Disease / genetics*
Polymorphism, Single Nucleotide / genetics*
Protein Serine-Threonine Kinases / genetics*
South Africa
White People

Substances

LRRK2 protein, human
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
Protein Serine-Threonine Kinases

Grants and funding